JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 1, 2004; DOI: 10.1124/jpet.104.070805


0022-3565/04/3112-748-757$20.00
JPET 311:748-757, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.070805v1
311/2/748    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, C.
Right arrow Articles by Hryshko, L. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, C.
Right arrow Articles by Hryshko, L. V.

CARDIOVASCULAR

Inhibitory Profile of SEA0400 [2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] Assessed on the Cardiac Na+-Ca2+ Exchanger, NCX1.1

Candace Lee, Neeraj S. Visen, Naranjan S. Dhalla, Hoa Dinh Le, Michael Isaac, Platon Choptiany, Gil Gross, Alexander Omelchenko, Toshio Matsuda, Akemichi Baba, Kenzo Takahashi, Mark Hnatowich, and Larry V. Hryshko

Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada (C.L., N.S.V., N.S.D., H.D.L., M.I., P.C., A.O., M.H., L.V.H.); Division of Cardiology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada (G.G.); Graduate School of Pharmaceutical Sciences, Osaka University, Yamada-oka, Suita, Osaka, Japan (T.M., A.B.); and Taisho Pharmaceutical Co., Ltd., Takata 3-Chome, Toshimaku, Tokyo, Japan (K.T.)

SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline) has recently been described as a potent and selective inhibitor of Na+-Ca2+ exchange in cardiac, neuronal, and renal preparations. The inhibitory effects of SEA0400 were investigated on the cloned cardiac Na+-Ca2+ exchanger, NCX1.1, expressed in Xenopus laevis oocytes to gain insight into its inhibitory mechanism. Na+-Ca2+ exchange currents were measured using the giant excised patch technique using conditions to evaluate both inward and outward currents. SEA0400 inhibited outward Na+-Ca2+ exchange currents with high affinity (IC50 = 78 ± 15 and 23 ± 4 nM for peak and steady-state currents, respectively). Considerably less inhibitory potency (i.e., micromolar) was observed for inward currents. The inhibitory profile was reexamined after proteolytic treatment of excised patches with {alpha}-chymotrypsin, a procedure that eliminates ionic regulatory mechanisms. After this treatment, an IC50 value of 1.2 ± 0.6 µM was estimated for outward currents, whereas inward currents became almost insensitive to SEA0400. The inhibitory effects of SEA0400 on outward exchange currents were evident at both high and low concentrations of regulatory Ca2+, although distinct features were noted. SEA0400 accelerated the inactivation rate of outward currents. Based on paired pulse experiments, SEA0400 altered the recovery of exchangers from the Na+i-dependent inactive state, particularly at higher regulatory Ca2+i concentrations. Finally, the inhibitory potency of SEA0400 was strongly dependent on the intracellular Na+ concentration. Our data confirm that SEA0400 is the most potent inhibitor of the cardiac Na+-Ca2+ exchanger described to date and provide a reasonable explanation for its apparent transport mode selectivity.


Received April 29, 2004; accepted July 1, 2004.

Address correspondence to: Dr. Larry V. Hryshko, Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6. E-mail: lhryshko{at}sbrc.ca




This article has been cited by other articles:


Home page
EuropaceHome page
G. Antoons and K. R. Sipido
Targeting calcium handling in arrhythmias
Europace, October 9, 2008; (2008) eun271v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Hryshko
What regulates Na+/Ca2+ exchange? Focus on "Sodium-dependent inactivation of sodium/calcium exchange in transfected Chinese hamster ovary cells"
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C869 - C871.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. Ozdemir, V. Bito, P. Holemans, L. Vinet, J.-J. Mercadier, A. Varro, and K. R. Sipido
Pharmacological Inhibition of Na/Ca Exchange Results in Increased Cellular Ca2+ Load Attributable to the Predominance of Forward Mode Block
Circ. Res., June 6, 2008; 102(11): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Savelieva and J. Camm
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
Europace, June 1, 2008; 10(6): 647 - 665.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Birinyi, A. Toth, I. Jona, K. Acsai, J. Almassy, N. Nagy, J. Prorok, I. Gherasim, Z. Papp, Z. Hertelendi, et al.
The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes
Cardiovasc Res, June 1, 2008; 78(3): 476 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. P. Sergeant, M. A. Hollywood, N. G. McHale, and K. D. Thornbury
Ca2+ signalling in urethral interstitial cells of Cajal
J. Physiol., November 1, 2006; 576(3): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Bradley, M. A. Hollywood, L. Johnston, R. J. Large, T. Matsuda, A. Baba, N. G. McHale, K. D. Thornbury, and G. P. Sergeant
Contribution of reverse Na+-Ca2+ exchange to spontaneous activity in interstitial cells of Cajal in the rabbit urethra
J. Physiol., August 1, 2006; 574(3): 651 - 661.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Iwamoto
Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Dipolo and L. Beauge
Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions
Physiol Rev, January 1, 2006; 86(1): 155 - 203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Beauge and R. DiPolo
SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1374 - C1380.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.